Participants at the “2017 Polish Conference of Applied Sciences” organized by PAP on Monday said that organizational, financial and spiritual barriers prevented Polish universities from effectively transferring innovation to industry.
Participants discussed issues related to the commercialization of Polish research results in recent years. Jan Filip Staniłko, Director of the Innovation Department of the Ministry of Entrepreneurship and Technology, believes that the root of the problem lies in finances. He believes that it is difficult to find customers for certain types of solutions in Poland today, such as advanced semiconductor solutions or biotechnology products, whose registration costs exceed the capabilities of Polish entities.
There are also problems with universities. For example, one of them is the lack of a mechanism to reward activities related to commercialization-the MPT representative added. “If the university does not receive a financial reward in the investment algorithm on the transfer part, then why do it?”-he said.
He also pointed out the historical origin of the entrepreneurship problem. “The entire economy and the entire science have not been involved in creating new things or new services for decades. Polish innovation is very imitated-we often look for solutions that cannot be imported. There is also an alternative logic: manufacturing Polish electronic products from scratch, in many cases There are still political obstacles,” he recalled.
Dr. Jerzy Kalinowski, consultant to the KPMG Management Committee, added that from a longer perspective of three to five years, Polish companies have not been strategically thinking for many years. “They live here now, and they will live now in three months. If they can’t pay off their R&D investment within 6 to 12 months, it will be meaningless,” he pointed out.
He added that Polish entrepreneurs believe that the current systemic convenience for innovation is mainly the possibility of obtaining additional funds-or through the prism of obtaining additional allowances.
Dr. Kalinowski added that it takes time to create “a dialogue between industry and academia.” “Not everything will suddenly become unexpected, and the indicators will rise in two or three years.” He said: “Because this is a huge cultural change, it involves both scientists and business. “
On the other hand, Jacek Klimek from Kujawsko-Pomorskie Klaster Brewster pointed out that compared with medicine or biological sciences, Poland has the greatest chance of success in the information and technology (ICT) industry, which requires relatively little financial expenditure.
Experts also expressed doubts about measuring innovation in the country based on patents. He said: “The problem is that it costs a lot of money.” He said: “It is completely absurd to expect a patent to be funded by a young scientist whose annual salary is about the national average.” He added that currently, it is used to help obtain The subsidy for patent financing only accounts for 50-60%. These costs.
Katarzyna Samsel of the National Research and Development Center pointed out that science and business are not two isolated worlds. “More and more scientists, young and old, are beginning to think in this way: If I have not joined any entrepreneurs now, maybe I will start my own business and realize my ideas in the market. Moreover, More and more entrepreneurs are asking for quotes to NCBR, and-as she said-“it turns out that they have a large number of scientists on the board, including employees.”
Jan Filip Staniłko pointed out that Poland’s expenditure structure for research and development has been correct. “Enterprises are already spending a bit more than the public sector. On the other hand, in the OECD, innovation activities have grown the most, starting at a very small level, but growing very fast. And our employment in the R&D sector is constantly increasing. Growth”-he explained. He added that this change is visible, but its possible impact will be felt for a long time.
Eliza Kruczkowska of the Polish Development Foundation pointed out the limitations of research investment from the perspective of investors. She said: “Investing in the commercialization of scientific research is first of all very risky, and investors often abandon it.” She added: “Secondly, it is very time-consuming: investors tend to avoid the 5 to 7-year development period.”
On the other hand, as pointed out by Dr. Maciej Paszewski of the Center for Innovation and Technology Transfer at Warsaw University of Life Sciences, university policymakers are very concerned about cooperation with companies. “What we generate in the center is a percentage of the university budget. Now: From his point of view, how much time should this director or dean spend making risky decisions?”-he is asking.
Paszewski also pointed out that research projects prepared by scientists often fail to meet the expectations of financial investors. Scientists came up with some ideas, and the project investors were looking for explained how much it would cost and when it would appear on the market. He said that in universities, there is no money and there may not be a source of outstanding abilities.
Conversely, Dr. Robert Dwiliński of the University Center for Technology Transfer at the University of Warsaw took Polish medical science as an example and expressed his firm belief that it is impossible to “introduce breakthrough innovations that require a lot of investment” in Poland.
“There is no government policy to provide these opportunities. Dwiliński pointed out: “Maybe it is because our country is too poor, maybe it is because we have scattered too many resources. He emphasized: “If we only produce start-ups that have no further development opportunities in the country, the result will be that these start-ups will only be acquired by foreign companies, which will obviously benefit from it. ”
PAP-Science of Poland
kflo/ zan/ agt/ zan/